Form D · Biotechnology
SENEX BIOTECHNOLOGY INC
Columbia, SC · CIK 0001278295
Offering snapshot reported Sep 12, 2013 · SEC filing
- Reported sold
- $426K Offering amount: $426K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 30, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 12, 2013 | Initial | $426,079 | No comparison | 1 | SEC filing |
| Aug 5, 2013 | Initial | $400,000 | No comparison | 2 | SEC filing |
| May 11, 2011 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-202739
Source: Form D, filed Sep 12, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Davidson | Director |
| Lawrence T. Friedhoff | Director, Executive |
| L James Miller | Director |
| Igor Roninson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Coker Life Sciences Building, Room 513 715 Sumter St.
Columbia, SC, 29280
Columbia, SC, 29280